That all depends on what they say on friday. If they say the capital is for a rapid market expansion of brevagen or for an acquisition that positions the company for growth than I would expect it to continue it's rise. But if its just a simple dilution for company expenses (which I don't believe will be the case) than we'll get popped pretty good. Impossible to say how much though.